8 Reasons for less weight loss with GLP1 RAs for T2D could include use of insulin or other obesity-promoting medications, concerns over hypoglycemia, decreased glycosuria, microbiome variation, genetic predisposition towards weight gain, and differences in endogenous GLP-1 pathways in the brain and other tissues
Promisingly, because GLP-1 medications promote weight loss and, therefore, reduce fat tissue, they might help downregulate pro-inflammatory molecules
Glutathione is a highly effective antioxidant with wide-ranging benefits, especially when combined with NAC and Vitamin C
See our tirzepatide research guide for comparison context
Reglory PN Skin Boosteris formulated with a precision-balanced regenerative complex designed to support visible skin renewal, hydration, and long-term barrier strength